Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

A simple clinical assessment is superior to systematic triage in prediction of mortality in the emergency department.

Iversen AKS, Kristensen M, Østervig RM, Køber L, Sölétormos G, Lundager Forberg J, Eugen-Olsen J, Rasmussen LS, Schou M, Iversen KK.

Emerg Med J. 2019 Feb;36(2):66-71. doi: 10.1136/emermed-2016-206382. Epub 2018 Oct 16.

PMID:
30327415
2.

Routine blood tests are associated with short term mortality and can improve emergency department triage: a cohort study of >12,000 patients.

Kristensen M, Iversen AKS, Gerds TA, Østervig R, Linnet JD, Barfod C, Lange KHW, Sölétormos G, Forberg JL, Eugen-Olsen J, Rasmussen LS, Schou M, Køber L, Iversen K.

Scand J Trauma Resusc Emerg Med. 2017 Nov 28;25(1):115. doi: 10.1186/s13049-017-0458-x.

3.

The formation and design of the TRIAGE study--baseline data on 6005 consecutive patients admitted to hospital from the emergency department.

Plesner LL, Iversen AK, Langkjær S, Nielsen TL, Østervig R, Warming PE, Salam IA, Kristensen M, Schou M, Eugen-Olsen J, Forberg JL, Køber L, Rasmussen LS, Sölétormos G, Pedersen BK, Iversen K.

Scand J Trauma Resusc Emerg Med. 2015 Dec 1;23:106. doi: 10.1186/s13049-015-0184-1.

4.

[No evidence that formalized triage is superior to informally structured triage].

Iversen AK, Kristensen M, Østervig R, Forberg JL, Schou M, Iversen K.

Ugeskr Laeger. 2015 Jul 20;177(30). pii: V09140470. Review. Danish.

PMID:
26240049
5.

HIV-infected sex workers with beneficial HLA-variants are potential hubs for selection of HIV-1 recombinants that may affect disease progression.

Chang CH, Kist NC, Stuart Chester TL, Sreenu VB, Herman M, Luo M, Lunn D, Bell J, Plummer FA, Ball TB, Katzourakis A, Iversen AK.

Sci Rep. 2015 Jun 17;5:11253. doi: 10.1038/srep11253.

6.

Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.

Armitage AE, Deforche K, Welch JJ, Van Laethem K, Camacho R, Rambaut A, Iversen AK.

J Virol. 2014 Nov;88(21):12882-94. doi: 10.1128/JVI.01460-14. Epub 2014 Aug 27.

7.

HIV-1 adaptation to antigen processing results in population-level immune evasion and affects subtype diversification.

Tenzer S, Crawford H, Pymm P, Gifford R, Sreenu VB, Weimershaus M, de Oliveira T, Burgevin A, Gerstoft J, Akkad N, Lunn D, Fugger L, Bell J, Schild H, van Endert P, Iversen AKN.

Cell Rep. 2014 Apr 24;7(2):448-463. doi: 10.1016/j.celrep.2014.03.031. Epub 2014 Apr 13.

8.

Rapid antigen processing and presentation of a protective and immunodominant HLA-B*27-restricted hepatitis C virus-specific CD8+ T-cell epitope.

Schmidt J, Iversen AK, Tenzer S, Gostick E, Price DA, Lohmann V, Distler U, Bowness P, Schild H, Blum HE, Klenerman P, Neumann-Haefelin C, Thimme R.

PLoS Pathog. 2012;8(11):e1003042. doi: 10.1371/journal.ppat.1003042. Epub 2012 Nov 29.

9.

APOBEC3G-induced hypermutation of human immunodeficiency virus type-1 is typically a discrete "all or nothing" phenomenon.

Armitage AE, Deforche K, Chang CH, Wee E, Kramer B, Welch JJ, Gerstoft J, Fugger L, McMichael A, Rambaut A, Iversen AK.

PLoS Genet. 2012;8(3):e1002550. doi: 10.1371/journal.pgen.1002550. Epub 2012 Mar 22.

10.

Acute cytomegalovirus infection in Kenyan HIV-infected infants.

Slyker JA, Lohman-Payne BL, John-Stewart GC, Maleche-Obimbo E, Emery S, Richardson B, Dong T, Iversen AK, Mbori-Ngacha D, Overbaugh J, Emery VC, Rowland-Jones SL.

AIDS. 2009 Oct 23;23(16):2173-81. doi: 10.1097/QAD.0b013e32833016e8.

11.

Antigen processing influences HIV-specific cytotoxic T lymphocyte immunodominance.

Tenzer S, Wee E, Burgevin A, Stewart-Jones G, Friis L, Lamberth K, Chang CH, Harndahl M, Weimershaus M, Gerstoft J, Akkad N, Klenerman P, Fugger L, Jones EY, McMichael AJ, Buus S, Schild H, van Endert P, Iversen AK.

Nat Immunol. 2009 Jun;10(6):636-46. doi: 10.1038/ni.1728. Epub 2009 May 3.

PMID:
19412183
12.

Functional characteristics of HIV-1 subtype C compatible with increased heterosexual transmissibility.

Walter BL, Armitage AE, Graham SC, de Oliveira T, Skinhøj P, Jones EY, Stuart DI, McMichael AJ, Chesebro B, Iversen AK.

AIDS. 2009 Jun 1;23(9):1047-57. doi: 10.1097/QAD.0b013e32832a1806.

13.

Conserved footprints of APOBEC3G on Hypermutated human immunodeficiency virus type 1 and human endogenous retrovirus HERV-K(HML2) sequences.

Armitage AE, Katzourakis A, de Oliveira T, Welch JJ, Belshaw R, Bishop KN, Kramer B, McMichael AJ, Rambaut A, Iversen AK.

J Virol. 2008 Sep;82(17):8743-61. doi: 10.1128/JVI.00584-08. Epub 2008 Jun 18.

14.

Sequential broadening of CTL responses in early HIV-1 infection is associated with viral escape.

Karlsson AC, Iversen AK, Chapman JM, de Oliviera T, Spotts G, McMichael AJ, Davenport MP, Hecht FM, Nixon DF.

PLoS One. 2007 Feb 21;2(2):e225.

15.

Conflicting selective forces affect T cell receptor contacts in an immunodominant human immunodeficiency virus epitope.

Iversen AK, Stewart-Jones G, Learn GH, Christie N, Sylvester-Hviid C, Armitage AE, Kaul R, Beattie T, Lee JK, Li Y, Chotiyarnwong P, Dong T, Xu X, Luscher MA, MacDonald K, Ullum H, Klarlund-Pedersen B, Skinhøj P, Fugger L, Buus S, Mullins JI, Jones EY, van der Merwe PA, McMichael AJ.

Nat Immunol. 2006 Feb;7(2):179-89. Epub 2006 Jan 1.

PMID:
16388312
16.

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis.

Gao X, Bashirova A, Iversen AK, Phair J, Goedert JJ, Buchbinder S, Hoots K, Vlahov D, Altfeld M, O'Brien SJ, Carrington M.

Nat Med. 2005 Dec;11(12):1290-2. Epub 2005 Nov 20.

PMID:
16288280
17.

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine.

Dorrell L, Yang H, Iversen AK, Conlon C, Suttill A, Lancaster M, Dong T, Cebere I, Edwards A, Rowland-Jones S, Hanke T, McMichael AJ.

AIDS. 2005 Aug 12;19(12):1321-3.

PMID:
16052088
18.

Preferential detection of HIV subtype C' over subtype A in cervical cells from a dually infected woman.

Iversen AK, Learn GH, Skinhøj P, Mullins JI, McMichael AJ, Rambaut A.

AIDS. 2005 Jun 10;19(9):990-3. No abstract available.

PMID:
15905685
19.

Longitudinal and cross-sectional studies of HIV-1 RNA and DNA loads in blood and the female genital tract.

Iversen AK, Attermann J, Gerstoft J, Fugger L, Mullins JI, Skinhøj P.

Eur J Obstet Gynecol Reprod Biol. 2004 Dec 1;117(2):227-35.

PMID:
15541862
20.

Fetal antigen 1 (FA1) in the adult rat adrenal gland, ovary and pituitary gland.

Hedlund GP, Carlsson HE, Shieck E, Nilsson I, Lundblad C, Arons S, Iversen AK, Looman C, Jensen HE, Hau J.

In Vivo. 2003 Jan-Feb;17(1):1-4.

PMID:
12655782
21.

Limited protective effect of the CCR5Delta32/CCR5Delta32 genotype on human immunodeficiency virus infection incidence in a cohort of patients with hemophilia and selection for genotypic X4 virus.

Iversen AK, Christiansen CB, Attermann J, Eugen-Olsen J, Schulman S, Berntorp E, Ingerslev J, Fugger L, Scheibel E, Tengborn L, Gerstoft J, Dickmeiss E, Svejgaard A, Skinhøj P.

J Infect Dis. 2003 Jan 15;187(2):215-25. Epub 2003 Jan 6.

PMID:
12552446
22.

Genital HIV shedding in women.

Iversen AK.

AIDS Patient Care STDS. 1999 Dec;13(12):695-701.

PMID:
10743532
23.

Presence of multiple HIV subtypes and a high frequency of subtype chimeric viruses in heterosexually infected women.

Iversen AK, Learn GH, Fugger L, Gerstoft J, Mullins JI, Skinhoj P.

J Acquir Immune Defic Syndr. 1999 Dec 1;22(4):325-32.

PMID:
10634193
24.

Coalescent estimates of HIV-1 generation time in vivo.

Rodrigo AG, Shpaer EG, Delwart EL, Iversen AK, Gallo MV, Brojatsch J, Hirsch MS, Walker BD, Mullins JI.

Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2187-91.

25.

Cervical human immunodeficiency virus type 1 shedding is associated with genital beta-chemokine secretion.

Iversen AK, Fugger L, Eugen-Olsen J, Balslev U, Jensen T, Wahl S, Gerstoft J, Mullins JI, Skinhoj P.

J Infect Dis. 1998 Nov;178(5):1334-42.

PMID:
9780253
26.

Chemokine receptor CCR2b 64I polymorphism and its relation to CD4 T-cell counts and disease progression in a Danish cohort of HIV-infected individuals. Copenhagen AIDS cohort.

Eugen-Olsen J, Iversen AK, Benfield TL, Koppelhus U, Garred P.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jun 1;18(2):110-6.

PMID:
9637575
27.

Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions.

Iversen AK, Larsen AR, Jensen T, Fugger L, Balslev U, Wahl S, Gerstoft J, Mullins JI, Skinhøj P.

J Infect Dis. 1998 May;177(5):1214-20.

PMID:
9593006
28.

HIV-infected individuals with the CCR delta32/CCR5 genotype have lower HIV RNA levels and higher CD4 cell counts in the early years of the infection than do patients with the wild type. Copenhagen AIDS Cohort Study Group.

Katzenstein TL, Eugen-Olsen J, Hofmann B, Benfield T, Pedersen C, Iversen AK, Sørensen AM, Garred P, Koppelhus U, Svejgaard A, Gerstoft J.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Sep 1;16(1):10-4.

PMID:
9377119
29.

Dual effect of CCR5 delta 32 gene deletion in HIV-1-infected patients. Copenhagen AIDS Study Group.

Garred P, Eugen-Olsen J, Iversen AK, Benfield TL, Svejgaard A, Hofmann B.

Lancet. 1997 Jun 28;349(9069):1884. No abstract available.

PMID:
9217763
30.

Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals.

Eugen-Olsen J, Iversen AK, Garred P, Koppelhus U, Pedersen C, Benfield TL, Sorensen AM, Katzenstein T, Dickmeiss E, Gerstoft J, Skinhøj P, Svejgaard A, Nielsen JO, Hofmann B.

AIDS. 1997 Mar;11(3):305-10.

PMID:
9147421
32.

Multidrug-resistant human immunodeficiency virus type 1 strains resulting from combination antiretroviral therapy.

Iversen AK, Shafer RW, Wehrly K, Winters MA, Mullins JI, Chesebro B, Merigan TC.

J Virol. 1996 Feb;70(2):1086-90.

33.

Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual.

Iversen AK, Shpaer EG, Rodrigo AG, Hirsch MS, Walker BD, Sheppard HW, Merigan TC, Mullins JI.

J Virol. 1995 Sep;69(9):5743-53.

35.

Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations.

Shafer RW, Kozal MJ, Winters MA, Iversen AK, Katzenstein DA, Ragni MV, Meyer WA 3rd, Gupta P, Rasheed S, Coombs R, et al.

J Infect Dis. 1994 Apr;169(4):722-9.

PMID:
8133086
36.

Detection of human papillomavirus type 16 DNA sequences in archival cervical tissues by the polymerase chain reaction.

Hørding U, Daugaard S, Iversen AK, Bock JE, Philip J.

Arch Pathol Lab Med. 1992 Jun;116(6):632-4.

PMID:
1319702
37.

The prevalence of human papillomavirus in cervical lesions with koilocytosis and/or CIN I.

Iversen AK, Duun S, Sebbelov AM, Norrild B.

APMIS. 1992 Mar;100(3):280-6.

PMID:
1314062
38.

Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro.

Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AK, Colvin D, Gallo MV, Coutre S, Shpaer EG, et al.

J Virol. 1992 Feb;66(2):875-85.

39.

Human papillomavirus type 16 in vulvar carcinoma, vulvar intraepithelial neoplasia, and associated cervical neoplasia.

Hørding U, Daugaard S, Iversen AK, Knudsen J, Bock JE, Norrild B.

Gynecol Oncol. 1991 Jul;42(1):22-6.

PMID:
1655593
40.

Prevalence of human papillomavirus types 11, 16 and 18 in cervical swabs. A study of 1362 pregnant women.

Hørding U, Iversen AK, Sebbelov A, Bock JE, Norrild B.

Eur J Obstet Gynecol Reprod Biol. 1990 May-Jun;35(2-3):191-8.

PMID:
2159427

Supplemental Content

Loading ...
Support Center